Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C
Top Cited Papers
Open Access
- 1 July 2005
- Vol. 54 (7), 1003-1008
- https://doi.org/10.1136/gut.2004.050302
Abstract
Background: Insulin resistance is a frequent feature of chronic hepatitis C. Whether insulin resistance could be the cause or consequence of steatosis and fibrosis is unknown. The ability of HCV genotype 3 to promote steatosis by itself provides an unique opportunity to answer this question. Aims: The aim of the present study was to assess the relationships between insulin resistance, steatosis, and fibrosis according to genotype in 141 non-diabetic patients with biopsy proven non-cirrhotic chronic hepatitis C. Methods: All patients had fasting serum glycaemia and insulinaemia measurements. Insulin resistance was evaluated using the homeostasis model assessment (HOMA IR) method. Liver steatosis was determined according to hepatitis C virus genotype (1 or 3). Logistic regression and multivariate regression analysis were used to identify variables independently associated with insulin resistance, fatty liver, and fibrosis. Results: Although steatosis and fibrosis were more severe in genotype 3 patients, median HOMA IR was significantly higher in patients with genotype 1 related steatosis than in those with genotype 3 related steatosis (2.1 v 1; p = 0.001). Independent risk factors for steatosis were insulin resistance in genotype 1 patients (p = 0.001) and viral load in genotype 3 patients (p = 0.003). Among genotype 1 patients, independent parameters associated with insulin resistance were age (p = 0.04) and steatosis (p = 0.004). Steatosis was associated with more severe fibrosis whatever the genotype (p = 0.002). Among genotype 1 patients, although there was a significant relationship between circulating insulin level and fibrosis stage (p = 0.006), only steatosis and inflammatory score were independently associated with fibrosis. Conclusion: This study shows that insulin resistance is the cause rather than the consequence of steatosis and fibrosis in genotype 1 patients and that increased circulating insulin is a risk factor for fibrosis through insulin resistance induced steatosis.Keywords
This publication has 45 references indexed in Scilit:
- Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistanceGastroenterology, 2004
- Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistanceNature Medicine, 2004
- Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progressionGastroenterology, 2003
- Impaired IRS-1/PI3-kinase signaling in patients with HCV: A mechanism for increased prevalence of type 2 diabetesHepatology, 2003
- Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazoneHepatology, 2003
- Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin ResistanceScience, 2003
- Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic ConferenceHepatology, 2003
- Progression of fibrosis in chronic hepatitis CGastroenterology, 2003
- Steatosis in chronic hepatitis C: Relative contributions of obesity, diabetes mellitus, and alcoholHepatology, 2002
- Effect of The Interaction Between Steatosis and Alcohol Intake on Liver Fibrosis Progression in Chronic Hepatitis CThe American Journal of Gastroenterology, 2002